Eric Benevich
Corporate Officer/Principal at NEUROCRINE BIOSCIENCES, INC.
Net worth: 6 M $ as of 30/04/2024
Eric Benevich active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2015 | - |
Career history of Eric Benevich
Former positions of Eric Benevich
| Companies | Position | Start | End |
|---|---|---|---|
| AVANIR PHARMACEUTICALS INC | Public Communications Contact | 01/07/2005 | 01/01/2015 |
| Sales & Marketing | 30/12/2011 | 01/01/2015 | |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Sales & Marketing | - | - |
Training of Eric Benevich
| Washington State University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Sales & Marketing | 2 |
| Public Communications Contact | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
- Stock Market
- Insiders
- Eric Benevich
- Experience